Post Marketing Surveillance Study To Observe Safety And Efficacy Of Rapamune
Phase of Trial: Phase IV
Latest Information Update: 19 Jan 2017
At a glance
- Drugs Sirolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 03 Aug 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 22 Jul 2015 Planned End Date changed from 1 Sep 2015 to 1 Jul 2015, as reported by ClinicalTrials.gov.